In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Choi, K H
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone. [electronic resource] - The Journal of antimicrobial chemotherapy Apr 1997 - 509-14 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0305-7453
10.1093/jac/39.4.509 doi
Animals
Anti-Infective Agents--pharmacology
Bacterial Infections--prevention & control
Ciprofloxacin--pharmacology
Dose-Response Relationship, Drug
Enterococcus faecalis--drug effects
Fluoroquinolones
Gram-Negative Bacteria--drug effects
Gram-Positive Bacteria--drug effects
Male
Methicillin Resistance
Mice
Mice, Inbred ICR
Microbial Sensitivity Tests
Ofloxacin--pharmacology
Piperazines--pharmacology
Pseudomonas aeruginosa--drug effects
Quinolones--pharmacology
Staphylococcus aureus--drug effects
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone. [electronic resource] - The Journal of antimicrobial chemotherapy Apr 1997 - 509-14 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0305-7453
10.1093/jac/39.4.509 doi
Animals
Anti-Infective Agents--pharmacology
Bacterial Infections--prevention & control
Ciprofloxacin--pharmacology
Dose-Response Relationship, Drug
Enterococcus faecalis--drug effects
Fluoroquinolones
Gram-Negative Bacteria--drug effects
Gram-Positive Bacteria--drug effects
Male
Methicillin Resistance
Mice
Mice, Inbred ICR
Microbial Sensitivity Tests
Ofloxacin--pharmacology
Piperazines--pharmacology
Pseudomonas aeruginosa--drug effects
Quinolones--pharmacology
Staphylococcus aureus--drug effects